English
简体中文
Total: £ 56.28
Published Date: 2025-04-10 | Pages: 96 | Tables: 95 | Pharma & Healthcare
The global market for Mesalamine was valued at US$ 186 million in the year 2024 and is projected to reach a revised size of US$ 239 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Mesalamine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mesalamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine.
The Mesalamine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mesalamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Segment by Type
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
Segment by Application
Tablets
Capsules
Granule
Suppository
Enema
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mesalamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Mesalamine Market Overview
1.1 Product Definition
1.2 Mesalamine by Type
1.2.1 Global Mesalamine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Mesalamine by Application
1.3.1 Global Mesalamine Market Value by Application (2024 VS 2031)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Global Mesalamine Market Size Estimates and Forecasts
1.4.1 Global Mesalamine Revenue 2020-2031
1.4.2 Global Mesalamine Sales 2020-2031
1.4.3 Global Mesalamine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mesalamine Market Competition by Manufacturers
2.1 Global Mesalamine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mesalamine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mesalamine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mesalamine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mesalamine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mesalamine, Product Type & Application
2.7 Global Key Manufacturers of Mesalamine, Date of Enter into This Industry
2.8 Global Mesalamine Market Competitive Situation and Trends
2.8.1 Global Mesalamine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mesalamine Players Market Share by Revenue
2.8.3 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mesalamine Market Scenario by Region
3.1 Global Mesalamine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mesalamine Sales by Region: 2020-2031
3.2.1 Global Mesalamine Sales by Region: 2020-2025
3.2.2 Global Mesalamine Sales by Region: 2026-2031
3.3 Global Mesalamine Revenue by Region: 2020-2031
3.3.1 Global Mesalamine Revenue by Region: 2020-2025
3.3.2 Global Mesalamine Revenue by Region: 2026-2031
3.4 North America Mesalamine Market Facts & Figures by Country
3.4.1 North America Mesalamine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mesalamine Sales by Country (2020-2031)
3.4.3 North America Mesalamine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mesalamine Market Facts & Figures by Country
3.5.1 Europe Mesalamine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mesalamine Sales by Country (2020-2031)
3.5.3 Europe Mesalamine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mesalamine Market Facts & Figures by Region
3.6.1 Asia Pacific Mesalamine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mesalamine Sales by Region (2020-2031)
3.6.3 Asia Pacific Mesalamine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mesalamine Market Facts & Figures by Country
3.7.1 Latin America Mesalamine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mesalamine Sales by Country (2020-2031)
3.7.3 Latin America Mesalamine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mesalamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Mesalamine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mesalamine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mesalamine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mesalamine Sales by Type (2020-2031)
4.1.1 Global Mesalamine Sales by Type (2020-2025)
4.1.2 Global Mesalamine Sales by Type (2026-2031)
4.1.3 Global Mesalamine Sales Market Share by Type (2020-2031)
4.2 Global Mesalamine Revenue by Type (2020-2031)
4.2.1 Global Mesalamine Revenue by Type (2020-2025)
4.2.2 Global Mesalamine Revenue by Type (2026-2031)
4.2.3 Global Mesalamine Revenue Market Share by Type (2020-2031)
4.3 Global Mesalamine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mesalamine Sales by Application (2020-2031)
5.1.1 Global Mesalamine Sales by Application (2020-2025)
5.1.2 Global Mesalamine Sales by Application (2026-2031)
5.1.3 Global Mesalamine Sales Market Share by Application (2020-2031)
5.2 Global Mesalamine Revenue by Application (2020-2031)
5.2.1 Global Mesalamine Revenue by Application (2020-2025)
5.2.2 Global Mesalamine Revenue by Application (2026-2031)
5.2.3 Global Mesalamine Revenue Market Share by Application (2020-2031)
5.3 Global Mesalamine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 PharmaZell
6.1.1 PharmaZell Company Information
6.1.2 PharmaZell Description and Business Overview
6.1.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 PharmaZell Mesalamine Product Portfolio
6.1.5 PharmaZell Recent Developments/Updates
6.2 Syntese A/S
6.2.1 Syntese A/S Company Information
6.2.2 Syntese A/S Description and Business Overview
6.2.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Syntese A/S Mesalamine Product Portfolio
6.2.5 Syntese A/S Recent Developments/Updates
6.3 Cambrex Corporation
6.3.1 Cambrex Corporation Company Information
6.3.2 Cambrex Corporation Description and Business Overview
6.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cambrex Corporation Mesalamine Product Portfolio
6.3.5 Cambrex Corporation Recent Developments/Updates
6.4 Divis Laboratories
6.4.1 Divis Laboratories Company Information
6.4.2 Divis Laboratories Description and Business Overview
6.4.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Divis Laboratories Mesalamine Product Portfolio
6.4.5 Divis Laboratories Recent Developments/Updates
6.5 Chemi SpA
6.5.1 Chemi SpA Company Information
6.5.2 Chemi SpA Description and Business Overview
6.5.3 Chemi SpA Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Chemi SpA Mesalamine Product Portfolio
6.5.5 Chemi SpA Recent Developments/Updates
6.6 Ipca Laboratories
6.6.1 Ipca Laboratories Company Information
6.6.2 Ipca Laboratories Description and Business Overview
6.6.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ipca Laboratories Mesalamine Product Portfolio
6.6.5 Ipca Laboratories Recent Developments/Updates
6.7 Hangzhou Brother
6.7.1 Hangzhou Brother Company Information
6.7.2 Hangzhou Brother Description and Business Overview
6.7.3 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hangzhou Brother Mesalamine Product Portfolio
6.7.5 Hangzhou Brother Recent Developments/Updates
6.8 Lianyungang Fengheng Biopharm
6.8.1 Lianyungang Fengheng Biopharm Company Information
6.8.2 Lianyungang Fengheng Biopharm Description and Business Overview
6.8.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lianyungang Fengheng Biopharm Mesalamine Product Portfolio
6.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
6.9 Lasa Loboratory
6.9.1 Lasa Loboratory Company Information
6.9.2 Lasa Loboratory Description and Business Overview
6.9.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lasa Loboratory Mesalamine Product Portfolio
6.9.5 Lasa Loboratory Recent Developments/Updates
6.10 Corden Pharma Bergamo
6.10.1 Corden Pharma Bergamo Company Information
6.10.2 Corden Pharma Bergamo Description and Business Overview
6.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Corden Pharma Bergamo Mesalamine Product Portfolio
6.10.5 Corden Pharma Bergamo Recent Developments/Updates
6.11 Erregierre SpA
6.11.1 Erregierre SpA Company Information
6.11.2 Erregierre SpA Description and Business Overview
6.11.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Erregierre SpA Mesalamine Product Portfolio
6.11.5 Erregierre SpA Recent Developments/Updates
6.12 CTX Lifescience
6.12.1 CTX Lifescience Company Information
6.12.2 CTX Lifescience Description and Business Overview
6.12.3 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CTX Lifescience Mesalamine Product Portfolio
6.12.5 CTX Lifescience Recent Developments/Updates
6.13 Ishita Active Pharma Ingredients
6.13.1 Ishita Active Pharma Ingredients Company Information
6.13.2 Ishita Active Pharma Ingredients Description and Business Overview
6.13.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ishita Active Pharma Ingredients Mesalamine Product Portfolio
6.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
6.14 YC Biotech (Jiangsu)
6.14.1 YC Biotech (Jiangsu) Company Information
6.14.2 YC Biotech (Jiangsu) Description and Business Overview
6.14.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 YC Biotech (Jiangsu) Mesalamine Product Portfolio
6.14.5 YC Biotech (Jiangsu) Recent Developments/Updates
6.15 Xinxiang Tianfeng Fine Chemical
6.15.1 Xinxiang Tianfeng Fine Chemical Company Information
6.15.2 Xinxiang Tianfeng Fine Chemical Description and Business Overview
6.15.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolio
6.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mesalamine Industry Chain Analysis
7.2 Mesalamine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mesalamine Production Mode & Process Analysis
7.4 Mesalamine Sales and Marketing
7.4.1 Mesalamine Sales Channels
7.4.2 Mesalamine Distributors
7.5 Mesalamine Customer Analysis
8 Mesalamine Market Dynamics
8.1 Mesalamine Industry Trends
8.2 Mesalamine Market Drivers
8.3 Mesalamine Market Challenges
8.4 Mesalamine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Mesalamine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Mesalamine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Mesalamine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Mesalamine Sales (Tons) of Key Manufacturers (2020-2025)
Table 5. Global Mesalamine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Mesalamine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Mesalamine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Mesalamine Average Price (US$/kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Mesalamine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mesalamine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mesalamine, Product Type & Application
Table 12. Global Key Manufacturers of Mesalamine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mesalamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mesalamine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Mesalamine Sales by Region (2020-2025) & (Tons)
Table 18. Global Mesalamine Sales Market Share by Region (2020-2025)
Table 19. Global Mesalamine Sales by Region (2026-2031) & (Tons)
Table 20. Global Mesalamine Sales Market Share by Region (2026-2031)
Table 21. Global Mesalamine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Mesalamine Revenue Market Share by Region (2020-2025)
Table 23. Global Mesalamine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Mesalamine Revenue Market Share by Region (2026-2031)
Table 25. North America Mesalamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Mesalamine Sales by Country (2020-2025) & (Tons)
Table 27. North America Mesalamine Sales by Country (2026-2031) & (Tons)
Table 28. North America Mesalamine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Mesalamine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Mesalamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Mesalamine Sales by Country (2020-2025) & (Tons)
Table 32. Europe Mesalamine Sales by Country (2026-2031) & (Tons)
Table 33. Europe Mesalamine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Mesalamine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Mesalamine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Mesalamine Sales by Region (2020-2025) & (Tons)
Table 37. Asia Pacific Mesalamine Sales by Region (2026-2031) & (Tons)
Table 38. Asia Pacific Mesalamine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Mesalamine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Mesalamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Mesalamine Sales by Country (2020-2025) & (Tons)
Table 42. Latin America Mesalamine Sales by Country (2026-2031) & (Tons)
Table 43. Latin America Mesalamine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mesalamine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Mesalamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Mesalamine Sales by Country (2020-2025) & (Tons)
Table 47. Middle East and Africa Mesalamine Sales by Country (2026-2031) & (Tons)
Table 48. Middle East and Africa Mesalamine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Mesalamine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Mesalamine Sales (Tons) by Type (2020-2025)
Table 51. Global Mesalamine Sales (Tons) by Type (2026-2031)
Table 52. Global Mesalamine Sales Market Share by Type (2020-2025)
Table 53. Global Mesalamine Sales Market Share by Type (2026-2031)
Table 54. Global Mesalamine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Mesalamine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Mesalamine Revenue Market Share by Type (2020-2025)
Table 57. Global Mesalamine Revenue Market Share by Type (2026-2031)
Table 58. Global Mesalamine Price (US$/kg) by Type (2020-2025)
Table 59. Global Mesalamine Price (US$/kg) by Type (2026-2031)
Table 60. Global Mesalamine Sales (Tons) by Application (2020-2025)
Table 61. Global Mesalamine Sales (Tons) by Application (2026-2031)
Table 62. Global Mesalamine Sales Market Share by Application (2020-2025)
Table 63. Global Mesalamine Sales Market Share by Application (2026-2031)
Table 64. Global Mesalamine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Mesalamine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Mesalamine Revenue Market Share by Application (2020-2025)
Table 67. Global Mesalamine Revenue Market Share by Application (2026-2031)
Table 68. Global Mesalamine Price (US$/kg) by Application (2020-2025)
Table 69. Global Mesalamine Price (US$/kg) by Application (2026-2031)
Table 70. PharmaZell Company Information
Table 71. PharmaZell Description and Business Overview
Table 72. PharmaZell Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 73. PharmaZell Mesalamine Product
Table 74. PharmaZell Recent Developments/Updates
Table 75. Syntese A/S Company Information
Table 76. Syntese A/S Description and Business Overview
Table 77. Syntese A/S Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 78. Syntese A/S Mesalamine Product
Table 79. Syntese A/S Recent Developments/Updates
Table 80. Cambrex Corporation Company Information
Table 81. Cambrex Corporation Description and Business Overview
Table 82. Cambrex Corporation Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 83. Cambrex Corporation Mesalamine Product
Table 84. Cambrex Corporation Recent Developments/Updates
Table 85. Divis Laboratories Company Information
Table 86. Divis Laboratories Description and Business Overview
Table 87. Divis Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 88. Divis Laboratories Mesalamine Product
Table 89. Divis Laboratories Recent Developments/Updates
Table 90. Chemi SpA Company Information
Table 91. Chemi SpA Description and Business Overview
Table 92. Chemi SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 93. Chemi SpA Mesalamine Product
Table 94. Chemi SpA Recent Developments/Updates
Table 95. Ipca Laboratories Company Information
Table 96. Ipca Laboratories Description and Business Overview
Table 97. Ipca Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 98. Ipca Laboratories Mesalamine Product
Table 99. Ipca Laboratories Recent Developments/Updates
Table 100. Hangzhou Brother Company Information
Table 101. Hangzhou Brother Description and Business Overview
Table 102. Hangzhou Brother Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 103. Hangzhou Brother Mesalamine Product
Table 104. Hangzhou Brother Recent Developments/Updates
Table 105. Lianyungang Fengheng Biopharm Company Information
Table 106. Lianyungang Fengheng Biopharm Description and Business Overview
Table 107. Lianyungang Fengheng Biopharm Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 108. Lianyungang Fengheng Biopharm Mesalamine Product
Table 109. Lianyungang Fengheng Biopharm Recent Developments/Updates
Table 110. Lasa Loboratory Company Information
Table 111. Lasa Loboratory Description and Business Overview
Table 112. Lasa Loboratory Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 113. Lasa Loboratory Mesalamine Product
Table 114. Lasa Loboratory Recent Developments/Updates
Table 115. Corden Pharma Bergamo Company Information
Table 116. Corden Pharma Bergamo Description and Business Overview
Table 117. Corden Pharma Bergamo Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 118. Corden Pharma Bergamo Mesalamine Product
Table 119. Corden Pharma Bergamo Recent Developments/Updates
Table 120. Erregierre SpA Company Information
Table 121. Erregierre SpA Description and Business Overview
Table 122. Erregierre SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 123. Erregierre SpA Mesalamine Product
Table 124. Erregierre SpA Recent Developments/Updates
Table 125. CTX Lifescience Company Information
Table 126. CTX Lifescience Description and Business Overview
Table 127. CTX Lifescience Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 128. CTX Lifescience Mesalamine Product
Table 129. CTX Lifescience Recent Developments/Updates
Table 130. Ishita Active Pharma Ingredients Company Information
Table 131. Ishita Active Pharma Ingredients Description and Business Overview
Table 132. Ishita Active Pharma Ingredients Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 133. Ishita Active Pharma Ingredients Mesalamine Product
Table 134. Ishita Active Pharma Ingredients Recent Developments/Updates
Table 135. YC Biotech (Jiangsu) Company Information
Table 136. YC Biotech (Jiangsu) Description and Business Overview
Table 137. YC Biotech (Jiangsu) Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 138. YC Biotech (Jiangsu) Mesalamine Product
Table 139. YC Biotech (Jiangsu) Recent Developments/Updates
Table 140. Xinxiang Tianfeng Fine Chemical Company Information
Table 141. Xinxiang Tianfeng Fine Chemical Description and Business Overview
Table 142. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 143. Xinxiang Tianfeng Fine Chemical Mesalamine Product
Table 144. Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Mesalamine Distributors List
Table 148. Mesalamine Customers List
Table 149. Mesalamine Market Trends
Table 150. Mesalamine Market Drivers
Table 151. Mesalamine Market Challenges
Table 152. Mesalamine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mesalamine
Figure 2. Global Mesalamine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mesalamine Market Share by Type: 2024 & 2031
Figure 4. Purity ≥ 97% Product Picture
Figure 5. Purity ≥ 98% Product Picture
Figure 6. Purity ≥ 99% Product Picture
Figure 7. Global Mesalamine Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Mesalamine Market Share by Application: 2024 & 2031
Figure 9. Tablets
Figure 10. Capsules
Figure 11. Granule
Figure 12. Suppository
Figure 13. Enema
Figure 14. Others
Figure 15. Global Mesalamine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Mesalamine Market Size (2020-2031) & (US$ Million)
Figure 17. Global Mesalamine Sales (2020-2031) & (Tons)
Figure 18. Global Mesalamine Average Price (US$/kg) & (2020-2031)
Figure 19. Mesalamine Report Years Considered
Figure 20. Mesalamine Sales Share by Manufacturers in 2024
Figure 21. Global Mesalamine Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Mesalamine Players: Market Share by Revenue in Mesalamine in 2024
Figure 23. Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Mesalamine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Mesalamine Sales Market Share by Country (2020-2031)
Figure 26. North America Mesalamine Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Mesalamine Sales Market Share by Country (2020-2031)
Figure 30. Europe Mesalamine Revenue Market Share by Country (2020-2031)
Figure 31. Germany Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Mesalamine Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Mesalamine Revenue Market Share by Region (2020-2031)
Figure 38. China Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Mesalamine Sales Market Share by Country (2020-2031)
Figure 49. Latin America Mesalamine Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Mesalamine Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Mesalamine Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Mesalamine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Mesalamine by Type (2020-2031)
Figure 59. Global Revenue Market Share of Mesalamine by Type (2020-2031)
Figure 60. Global Mesalamine Price (US$/kg) by Type (2020-2031)
Figure 61. Global Sales Market Share of Mesalamine by Application (2020-2031)
Figure 62. Global Revenue Market Share of Mesalamine by Application (2020-2031)
Figure 63. Global Mesalamine Price (US$/kg) by Application (2020-2031)
Figure 64. Mesalamine Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
